SFWC
MIST icon

Strategic Family Wealth Counselors’s Milestone Pharmaceuticals MIST Stock Holding History

Strategic Family Wealth Counselors’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5K Buy
13,875
+1,200
+9% +$2.1K ﹤0.01% 163
2025
Q4 		$25.5K Buy
+12,675
New +$27.3K 0.01% 217

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Strategic Family Wealth Counselors's MIST Position: Q1 2026 in Review

Strategic Family Wealth Counselors increased its Milestone Pharmaceuticals (MIST) stake by 9.5% in Q1 2026, buying an estimated $2.1K and bringing the position to 13,875 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Strategic Family Wealth Counselors first reported a position in MIST in Q4 2025 and has held it in 2 quarters since. The position peaked at $25.5K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Strategic Family Wealth Counselors held 13,875 shares of Milestone Pharmaceuticals worth $16.5K as of Q1 2026.
  • Strategic Family Wealth Counselors bought 1,200 Milestone Pharmaceuticals shares in Q1 2026, an estimated $2.1K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Strategic Family Wealth Counselors's portfolio in Q1 2026, its #163 holding.
  • Strategic Family Wealth Counselors first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Strategic Family Wealth Counselors's Milestone Pharmaceuticals position peaked at $25.5K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Strategic Family Wealth Counselors's 13F filing for Q1 2026, filed 11 May 2026.